Literature DB >> 20525910

Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined.

Paul M Stewart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20525910     DOI： 10.1210/jc.2010-0633

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  14 in total

Review 1.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  Subclinical hypercortisolism: debatable or visible on the lightbox?

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

3.  Six controversial issues on subclinical Cushing's syndrome.

Authors:  Iacopo Chiodini; Adriana Albani; Alberto Giacinto Ambrogio; Michela Campo; Maria Cristina De Martino; Giorgia Marcelli; Valentina Morelli; Benedetta Zampetti; Annamaria Colao; Rosario Pivonello
Journal:  Endocrine       Date:  2016-07-12       Impact factor: 3.633

Review 4.  Endocrine incidentalomas--challenges imposed by incidentally discovered lesions.

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Nat Rev Endocrinol       Date:  2011-06-28       Impact factor: 43.330

5.  Cardiovascular and metabolic risk factors in patients with subclinical Cushing.

Authors:  Luigi Petramala; Federica Olmati; Antonio Concistrè; Riccardo Russo; Martina Mezzadri; Maurizio Soldini; Giuseppe De Vincentis; Gino Iannucci; Giorgio De Toma; Claudio Letizia
Journal:  Endocrine       Date:  2020-04-16       Impact factor: 3.633

Review 6.  Is metabolic syndrome a mild form of Cushing's syndrome?

Authors:  Armand Krikorian; Mehreen Khan
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

Review 7.  Adrenal incidentalomas and subclinical Cushing's syndrome.

Authors:  Dima Abdelmannan; David C Aron
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

Review 8.  Cushing's disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review.

Authors:  J Lindholm
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

9.  Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas.

Authors:  Miguel Debono; Mike Bradburn; Matthew Bull; Barney Harrison; Richard J Ross; John Newell-Price
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

10.  Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study.

Authors:  Miguel Debono; Rita Chadarevian; Richard Eastell; Richard J Ross; John Newell-Price
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.